Literature DB >> 20936495

Prophylaxis for venous thromboembolism: guidelines translated for the clinician.

Gregg Stashenko1, Renato D Lopes, David Garcia, John H Alexander, Victor F Tapson.   

Abstract

Venous thromboembolism is a major cause of morbidity and mortality worldwide and most often affects hospitalized postoperative surgical and medical patients. Venous thromboembolism prophylaxis undoubtedly improves the care of these patients, as demonstrated by the current literature and guidelines. Failure to prescribe prophylaxis when indicated, however, remains a vital health care concern. The American College of Chest Physicians (ACCP) published their most recent guidelines regarding venous thromboembolism prophylaxis in 2008. In this review, we aim to summarize the most recent ACCP prophylaxis guidelines with practical application and interpretation for the practicing physician. Here we present the most practical information from these guidelines and summarize essential recommendations in key tables. We will briefly review the grading system used in the guidelines for the level of evidence and the strength of the recommendation. We will then discuss the recommendations for prophylaxis in the various patient populations described in these guidelines including general and orthopedic surgery, gynecologic surgery, urologic surgery, thoracic surgery, neurosurgery, trauma, medical conditions, cancer patients, and critical care. In addition, we will discuss recent clinical trials regarding novel anticoagulants for venous thromboembolism prophylaxis and share some conclusions.

Entities:  

Mesh:

Year:  2011        PMID: 20936495     DOI: 10.1007/s11239-010-0522-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  54 in total

1.  Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline.

Authors:  Jennifer Hill; Tom Treasure
Journal:  Heart       Date:  2010-06       Impact factor: 5.994

2.  Thromboprophylaxis with rivaroxaban or enoxaparin did not differ for major bleeding in knee arthroplasty.

Authors:  Pieter W Kamphuisen
Journal:  ACP J Club       Date:  2008 Nov-Dec

Review 3.  The changing pattern of venous thromboembolic disease.

Authors:  A T Cohen; R A Edmondson; M J Phillips; V P Ward; V V Kakkar
Journal:  Haemostasis       Date:  1996 Mar-Apr

Review 4.  A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.

Authors:  Rebecca Tooher; Philippa Middleton; Clarabelle Pham; Robert Fitridge; Siohban Rowe; Wendy Babidge; Guy Maddern
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

5.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.

Authors:  John A Heit; W Michael O'Fallon; Tanya M Petterson; Christine M Lohse; Marc D Silverstein; David N Mohr; L Joseph Melton
Journal:  Arch Intern Med       Date:  2002-06-10

6.  A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.

Authors:  W H Geerts; R M Jay; K I Code; E Chen; J P Szalai; E A Saibil; P A Hamilton
Journal:  N Engl J Med       Date:  1996-09-05       Impact factor: 91.245

7.  Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin.

Authors:  D Green; M Y Lee; A C Lim; J S Chmiel; M Vetter; T Pang; D Chen; L Fenton; G M Yarkony; P R Meyer
Journal:  Ann Intern Med       Date:  1990-10-15       Impact factor: 25.391

8.  Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Gordon H Guyatt; Deborah J Cook; Roman Jaeschke; Stephen G Pauker; Holger J Schünemann
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

Authors:  Michael Rud Lassen; Gary E Raskob; Alexander Gallus; Graham Pineo; Dalei Chen; Ronald J Portman
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

10.  A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis.

Authors:  Samuel Z Goldhaber; Victor F Tapson
Journal:  Am J Cardiol       Date:  2004-01-15       Impact factor: 2.778

View more
  3 in total

1.  [Bedside implantation of a new temporary vena cava inferior filter : German results from the European ANGEL registry].

Authors:  S Baumann; T Becher; K Giannakopoulos; C Jabbour; C Fastner; I El-Battrawy; U Ansari; D Lossnitzer; M Behnes; A Alonso; T Kirschning; R Dissmann; O Kueck; D Stern; G Michels; M Borggrefe; I Akin
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05-03       Impact factor: 0.840

2.  Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks?

Authors:  Srinevas K Reddy; Ryan S Turley; Andrew S Barbas; Jennifer L Steel; Allan Tsung; J Wallis Marsh; Bryan M Clary; David A Geller
Journal:  J Gastrointest Surg       Date:  2011-06-21       Impact factor: 3.452

3.  Comparison of efficiency and safety of rivaroxaban, apixaban and enoxaparin for thromboprophylaxis after arthroplastic surgery: a meta-analysis.

Authors:  Zhi Yu; Ping Shan; Xiaoxia Yang; Xin-Jiang Lou
Journal:  Biosci Rep       Date:  2018-11-13       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.